These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 15609125

  • 21. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study.
    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Yoo KY, Kang D.
    BMC Cancer; 2005 Oct 31; 5():143. PubMed ID: 16259637
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P, Kajo K, Stanclova A, Szunyogh N, Galo S, Dussan CA, Minarik G, Visnovsky J, Danko J.
    Eur J Cancer Prev; 2008 Feb 31; 17(1):33-8. PubMed ID: 18090908
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Piazuelo E, Fuentes J, García-González MA, Jiménez P, Lanas A.
    Clin Ther; 2008 Jan 31; 30(1):121-30. PubMed ID: 18343248
    [Abstract] [Full Text] [Related]

  • 27. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):51-9. PubMed ID: 15632380
    [Abstract] [Full Text] [Related]

  • 28. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H, Loman N, Johannsson OT, Borg A, Olsson H.
    Eur J Cancer; 2005 Oct 05; 41(15):2312-20. PubMed ID: 16118051
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reproductive factors and breast cancer risk among older women.
    Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD.
    Breast Cancer Res Treat; 2007 May 05; 102(3):365-74. PubMed ID: 17033925
    [Abstract] [Full Text] [Related]

  • 31. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W.
    Pharmacogenet Genomics; 2006 Apr 05; 16(4):237-43. PubMed ID: 16538170
    [Abstract] [Full Text] [Related]

  • 32. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
    Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN.
    Cancer Lett; 2007 May 08; 249(2):249-55. PubMed ID: 17081685
    [Abstract] [Full Text] [Related]

  • 33. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
    Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y.
    Acta Oncol; 2006 May 08; 45(5):597-601. PubMed ID: 16864175
    [Abstract] [Full Text] [Related]

  • 34. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.
    Cancer Epidemiol Biomarkers Prev; 2008 May 08; 17(5):1082-7. PubMed ID: 18483329
    [Abstract] [Full Text] [Related]

  • 35. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S, Magnusson C, Humphreys K, Melhus H, Kindmark A, Stiger F, Branting M, Persson I, Baron J, Weiderpass E.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep 08; 16(9):1775-83. PubMed ID: 17855696
    [Abstract] [Full Text] [Related]

  • 36. Timing of familial breast cancer in sisters.
    Rebora P, Czene K, Reilly M.
    J Natl Cancer Inst; 2008 May 21; 100(10):721-7. PubMed ID: 18477799
    [Abstract] [Full Text] [Related]

  • 37. Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.
    Figueiredo JC, Knight JA, Cho S, Savas S, Onay UV, Briollais L, Goodwin PJ, McLaughlin JR, Andrulis IL, Ozcelik H.
    BMC Cancer; 2007 Jun 14; 7():99. PubMed ID: 17567920
    [Abstract] [Full Text] [Related]

  • 38. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A.
    Ann N Y Acad Sci; 2008 Sep 14; 1138():84-94. PubMed ID: 18837888
    [Abstract] [Full Text] [Related]

  • 39. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
    Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB.
    Anticancer Res; 1998 Sep 14; 18(3B):2095-9. PubMed ID: 9677474
    [Abstract] [Full Text] [Related]

  • 40. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.
    Breast Cancer Res; 2005 Sep 14; 7(3):R353-6. PubMed ID: 15987430
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.